Latest News about XBI
Recent news which mentions XBI
From InvestorPlace
2 Top Biotech Stocks to Buy in April
April 08, 2022
From Motley Fool
From InvestorPlace
ETFs attract strong inflows in March, but not ‘all boats’ were lifted. Here’s where the money flowed—and where it didn’t.
April 07, 2022
From MarketWatch
From InvestorPlace
From Benzinga
Investors Should Take a Look at the Beaten Down Biotech ETFs
March 18, 2022
From ETF Trends
3 Market ETF Stocks to Buy This Week on Fed Jitters
March 14, 2022
From InvestorPlace
2 Biotech Stocks That Could Make You Richer
March 02, 2022
From Motley Fool
3 Moonshot Stocks Insiders Are Buying. What Do They Know?
February 25, 2022
From InvestorPlace
This Trend Is the Biggest Risk to Biotech Investors Right Now
February 21, 2022
From Motley Fool
Get Ready for a Biotech ETF Comeback
February 17, 2022
From ETF Trends
3 Desirable Drug Stocks With Very Promising Pipelines
February 16, 2022
From InvestorPlace
3 Biotech Stocks That Are too Cheap to Ignore
February 10, 2022
From Motley Fool
3 Growth ETFs to Consider Buying During This Correction
January 29, 2022
From Motley Fool
Why Sorrento Therapeutics Stock Is Getting Hammered This Week
January 28, 2022
From Motley Fool
From MarketWatch
2 Biotech Stocks That Could Be 10-Baggers in 2022
January 26, 2022
From Motley Fool
As stock-market turbulence revs up, this ETF theme has drawn 32% of flows in 2022 so far: ‘This isn’t a flash in the pan’
January 20, 2022
From MarketWatch
3 Biotech Stocks to Buy That Are Under Severe Pressure
January 13, 2022
From InvestorPlace
My 3 Top Biotech Stock Picks for 2022
January 09, 2022
From Motley Fool
Whitney Tilson Names Cannabis ETF 'Favorite Pick For 2022' But Clock Is Ticking To Change US Regulations
January 03, 2022
From Benzinga
These are the best ETFs and themes to buy in 2022, and its all about yields, says Astoria Advisors
December 30, 2021
From MarketWatch
10 Bargain Stocks to Buy After Falling 30% in 2021
December 20, 2021
From InvestorPlace
3 Last-Minute Healthcare Stocking Stuffers
December 18, 2021
From Motley Fool
Forget crypto! Some ETF providers bet that this $800 billion industry in 2024 is fund investing’s new frontier
December 09, 2021
From MarketWatch
3 Beaten-Down Biotech Stocks -- Are They Bargains Now?
December 08, 2021
From Motley Fool
8 Beaten-Down Pharmaceutical Stocks That Could Skyrocket In 2022
December 07, 2021
From Motley Fool
Here's Why Biotech Stocks Adaptimmune Therapeutics, Agenus, and Ocugen All Crashed in November
December 04, 2021
From Motley Fool
3 Best Biopharma Stocks to Buy During This Industrywide Fire Sale
November 28, 2021
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.